학술논문

Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial
Document Type
Article
Source
In The Lancet Oncology December 2019 20(12):1730-1739
Subject
Primary Research
Articles
Language
ISSN
1470-2045